Jump to:
loading...| Preferred Name |
Adefovir Dipivoxil |
|
| Synonyms |
|
|
| Definitions |
A dipivoxil formulation of adefovir, a nucleoside reverse transcriptase inhibitor analog of adenosine with activity against hepatitis B virus (HBV), herpes virus, and human immunodeficiency virus (HIV). |
|
| ID |
http://purl.obolibrary.org/obo/NCIT_C28811 |
|
| Accepted_Therapeutic_Use_For |
Chronic Hepatitis B |
|
| CAS_Registry |
142340-99-6 |
|
| Chemical_Formula |
C20H32N5O8P |
|
| code |
C28811 |
|
| Contributing_Source |
FDA |
|
| definition |
A dipivoxil formulation of adefovir, a nucleoside reverse transcriptase inhibitor analog of adenosine with activity against hepatitis B virus (HBV), herpes virus, and human immunodeficiency virus (HIV). |
|
| FDA_UNII_Code |
U6Q8Z01514 |
|
| in_subset | ||
| label |
Adefovir Dipivoxil |
|
| Legacy Concept Name |
Adefovir |
|
| NCI_Drug_Dictionary_ID |
543979 |
|
| PDQ_Closed_Trial_Search_ID |
543979 |
|
| PDQ_Open_Trial_Search_ID |
543979 |
|
| Preferred_Name |
Adefovir Dipivoxil |
|
| prefixIRI |
NCIT:C28811 |
|
| prefLabel |
Adefovir Dipivoxil |
|
| Semantic_Type |
Pharmacologic Substance Nucleic Acid, Nucleoside, or Nucleotide |
|
| UMLS_CUI |
C0540694 |
|
| subClassOf |
Create mapping